Biologic treatments for psoriasis: the cost of alternative methods of dispensation of medication in Spain.

Objective: Hospital pharmacy services have adapted to the COVID‑19 pandemic. The aim of the study is to determine the economic  consequences of replacing hospital pharmacy dispensation with other  dispensing methods in the context of biological treatments for psoriasis in  Spain.

Method: Multiple dispensation scenarios were evaluated, combining different  dispensation frequencies and sites, and telepharmacy followup intervals.

Cost-effectiveness analysis of HLA-B*5701 typing in the prevention of hypersensitivity to abacavir in HIV+ patients in Spain.

Introduction: Approximately 4% to 8% of patients with HIV-1 treated with abacavir present a hypersensitivity reaction (HSR). Various studies have shown a direct association between human leukocyte antigen (HLA)-B*5701 and HSR to abacavir. The objective of this study was to analyze whether systematic HLA-B*5701 testing to prevent HSR in patients treated with abacavir is a cost-effective option for the Spanish National Health System.